Literature DB >> 4357127

Herpes genitalis treated by photodynamic inactivation of virus.

R H Kaufman, H L Gardner, D Brown, C Wallis, W E Rawls, J L Melnick.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4357127     DOI： 10.1016/0002-9378(73)90768-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  9 in total

1.  Neutral red with photoinactivation in the treatment of herpes genitalis.

Authors:  A P Roome; A E Tinkler; A L Hilton; D G Montefiore; D Waller
Journal:  Br J Vener Dis       Date:  1975-04

2.  Editorial: Treatment of genital herpes.

Authors: 
Journal:  Br Med J       Date:  1974-06-01

Review 3.  The latent herpes simplex virus.

Authors:  J J Docherty; M Chopan
Journal:  Bacteriol Rev       Date:  1974-12

4.  Comparison of the treatment of herpes genitalis in men with proflavine photoinactivation, idoxuridine ointment, and normal saline.

Authors:  P K Taylor; N R Doherty
Journal:  Br J Vener Dis       Date:  1975-04

5.  Miconazole nitrate compared with chlordantoin in the treatment of vaginal candidiasis.

Authors:  D F Morris; D L Sugrue
Journal:  Br J Vener Dis       Date:  1975-04

6.  Clinical and virologic course of herpes simplex genitalis.

Authors:  Z A Brown; E R Kern; S L Spruance; J C Overall
Journal:  West J Med       Date:  1979-05

Review 7.  Photodynamic therapy for localized infections--state of the art.

Authors:  Tianhong Dai; Ying-Ying Huang; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2009 Sep-Dec       Impact factor: 3.631

8.  Photoinactivation of latent herpes simplex virus in rabbit kidney cells.

Authors:  J J Kelleher; J Varani
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

9.  Early events in herpes simplex virus type 1 infection: photosensitivity of fluorescein isothiocyanate-treated virions.

Authors:  N DeLuca; D Bzik; S Person; W Snipes
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.